Treatment for Cellulitis of the Toe

Initial Assessment and Risk Stratification

The Infectious Diseases Society of America recommends assessing for specific MRSA risk factors, such as penetrating trauma or injection drug use, before selecting antibiotics 1, 2
The assessment should also include checking for purulent drainage or exudate, evidence of MRSA infection elsewhere or nasal colonization, and systemic inflammatory response syndrome (SIRS) 1, 2
Examining interdigital toe spaces for tinea pedis, fissuring, scaling, or maceration is also crucial, as treating these conditions can reduce recurrent infection risk 1, 2

For typical nonpurulent toe cellulitis, the American College of Physicians recommends beta-lactam monotherapy with cephalexin 500 mg orally every 6 hours or dicloxacillin 250-500 mg every 6 hours for 5 days 1, 2
The treatment duration should be extended only if symptoms have not improved within the initial 5-day timeframe, based on high-quality randomized controlled trial evidence 1, 2
For toe cellulitis with MRSA risk factors, adding MRSA coverage with clindamycin 300-450 mg orally every 6 hours or doxycycline 100 mg twice daily plus a beta-lactam is recommended 1, 2

The Infectious Diseases Society of America recommends clindamycin as the most appropriate empiric choice for diabetic patients with toe cellulitis, as it covers both streptococci and MRSA without requiring combination therapy 3, 4
For mild diabetic foot infections, oral agents including dicloxacillin, clindamycin, cephalexin, or amoxicillin-clavulanate are recommended 4, 3
Improving glycemic control is crucial in both eradicating infection and healing wounds in diabetic patients 5, 6, 3

The American College of Emergency Physicians recommends hospitalizing patients with toe cellulitis if they have systemic inflammatory response syndrome (SIRS), fever, hypotension, or altered mental status 5, 2
Other indications for hospitalization include severe immunocompromise or neutropenia, concern for deeper or necrotizing infection, critical limb ischemia, and social factors affecting wound care or adherence 5, 2

Elevating the affected foot above heart level to promote gravity drainage of edema and inflammatory substances is recommended 1, 2
Treating tinea pedis and interdigital toe web abnormalities is crucial in reducing recurrence risk 1, 2
Addressing venous insufficiency and lymphedema with compression stockings once acute infection resolves is also recommended 2

The Infectious Diseases Society of America recommends considering prophylactic antibiotics, such as oral penicillin or erythromycin twice daily for 4-52 weeks, for patients with 3-4 episodes of cellulitis per year despite treating predisposing factors 1
Intramuscular benzathine penicillin every 2-4 weeks is also an option for preventing recurrent cellulitis 1